EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Half-dose ticagrelor versus clopidogrel dual antiplatelet therapy in flow diverter-treated intracranial aneurysms: analysis of platelet reactivity and perioperative safety outcomes

Can Li, Hao Yuan, Chuanzhi Duan, Xin Feng, Wenchao Liu, Jiwan Huang, Chi Huang, Mengshi Huang, Zhuohua Wen, Runze Ge, Jiancheng Lin, Fa Jin und 5 weitere

Acta Neurochirurgica · 26.02.2026 · 168 (1)

DOI: 10.1007/s00701-026-06805-7 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Acta Neurochirurgica, online erschienen am 26.02.2026. Verfasst von Can Li und 16 weiteren Autor:innen. Beteiligte Einrichtung: Neurosurgery Center, Department of Cerebrovascular Surgery, Engineering Technology Research Center of Education Ministry of China on Diagnosis and Tr…. Hauptthemen laut MEDLINE: Intracranial Aneurysm, Platelet Aggregation Inhibitors, Clopidogrel, Ticagrelor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Foundation of National Heath Commission Capacity Building and Continuing Education Center, the Foundation of National Heath Commission Capacity Building and Continuing Education Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The safety and efficacy of half-dose ticagrelor (45 mg twice daily) dual antiplatelet therapy (DAPT) for flow diverter (FD) treatment of intracranial aneurysm (IA), particularly in Chinese patients and with PED (Pipeline embolization device) Flex Shield, remains uncertain. This study assessed whether this regimen maintains efficacy while improving safety, including its applicability to PED Flex Shield. METHODS: This single-center retrospective study analyzed consecutive IA patients undergoing FD treatment between 2019-2024, comparing standard-dose clopidogrel (75 mg daily) plus aspirin (100 mg daily) with half-dose ticagrelor (45 mg twice daily) plus aspirin (100 mg daily). Outcomes included adenosine diphosphate-induced maximal platelet aggregation (ADPi-MPA) measured by light transmittance aggregometry, perioperative complications within 30 days post-procedure, and analysis of factors influencing ADPi-MPA levels. RESULTS: The study included 405 IA patients (half-dose ticagrelor = 224, standard-dose clopidogrel = 181). The half-dose ticagrelor group demonstrated significantly lower ADPi-MPA (26.00 [17.45, 34.25] vs 37.70 [29.50, 43.60], P 0.05). Similarly, complication rates were comparable between the two DAPT regimens across both FD subgroups (all P > 0.05). CONCLUSION: This study demonstrates that half-dose ticagrelor DAPT achieves significantly lower platelet reactivity (ADPi-MPA) compared to standard-dose clopidogrel, with no statistically significant differences in ischemic or hemorrhagic complication rates observed among FD-treated IA patients. Importantly, the half-dose regimen shows consistent performance across different FD devices (including PED Flex Shield) without compromising perioperative safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intracranial AneurysmPlatelet Aggregation InhibitorsClopidogrelTicagrelorHumansFemaleMaleRetrospective StudiesMiddle AgedAspirinAgedPlatelet AggregationTreatment OutcomeDual Anti-Platelet TherapyAdultDrug Therapy, Combination

Stichwörter der Autor:innen

Dual antiplatelet therapyFlow diverterHalf-dose ticagrelorIntracranial aneurysm

Substanzen

Platelet Aggregation InhibitorsClopidogrelTicagrelorAspirin

Autor:innen und Institutionen

  • Neurosurgery Center, Department of Cerebrovascular Surgery, Engineering Technology Research Center of Education Ministry of China on Diagnosis and Treatment of Cerebrovascular Disease, Zhujiang Hospital, Southern Medica…

Förderung

  • Foundation of National Heath Commission Capacity Building and Continuing Education Center
  • the Foundation of National Heath Commission Capacity Building and Continuing Education Center

Zitieren

APA

Li, C., Yuan, H., Duan, C., Feng, X., Liu, W., Huang, J., Huang, C., Huang, M., Wen, Z., Ge, R., Lin, J., Jin, F., Li, R., Guo, S., Chen, C., Liang, S., & Li, X. (2026). Half-dose ticagrelor versus clopidogrel dual antiplatelet therapy in flow diverter-treated intracranial aneurysms: analysis of platelet reactivity and perioperative safety outcomes. Acta Neurochirurgica, 168(1). https://doi.org/10.1007/s00701-026-06805-7

Vancouver

Li C, Yuan H, Duan C, Feng X, Liu W, Huang J, et al. Half-dose ticagrelor versus clopidogrel dual antiplatelet therapy in flow diverter-treated intracranial aneurysms: analysis of platelet reactivity and perioperative safety outcomes. Acta Neurochirurgica. 2026;168(1). doi:10.1007/s00701-026-06805-7

BibTeX
@article{Li2026,
  author = {Li, Can and Yuan, Hao and Duan, Chuanzhi and Feng, Xin and Liu, Wenchao and Huang, Jiwan and Huang, Chi and Huang, Mengshi and Wen, Zhuohua and Ge, Runze and Lin, Jiancheng and Jin, Fa and Li, Ran and Guo, Shenquan and Chen, Chengwei and Liang, Shuyin and Li, Xifeng},
  title = {Half-dose ticagrelor versus clopidogrel dual antiplatelet therapy in flow diverter-treated intracranial aneurysms: analysis of platelet reactivity and perioperative safety outcomes},
  journal = {Acta Neurochirurgica},
  year = {2026},
  volume = {168},
  number = {1},
  doi = {10.1007/s00701-026-06805-7}
}
Kostenlos starten →